Featured Partners
Partners
Chiesi’s commitment to planet and patient care
Chiesi's unwavering commitment to both patient care and environmental sustainability sets a new standard in the pharmaceutical industry.
Defence announces Dr Maxime Parisotto as CSO, Director of Science and Business Development
Dr Maxime Parisotto is a seasoned biochemist with over 20 years of experience spanning academic research, drug development, and innovation.
Oak Hill Bio and Chiesi enrol first European patient in bronchopulmonary dysplasia treatment study
Oak Hill Bio and Chiesi Group have launched a groundbreaking study of a revolutionary bronchopulmonary dysplasia treatment for extremely premature infants.
Oak Hill Bio, a...